Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Zealand Pharma A/S ADR (ZEAL)

Zealand Pharma A/S ADR (ZEAL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Edgewise (EWTX) Up 9.37% on Positive Data From BMD Study

Edgewise (EWTX) stock gains on upbeat interim results from the ARCH study of its lead candidate EDG-5506 in adults with Becker Muscular Dystrophy (BMD).

DVAX : 11.22 (-3.19%)
ZEAL : 17.59 (+1.21%)
BOLT : 1.4500 (-3.33%)
EWTX : 10.26 (-4.38%)
Zealand Pharma Announces Financial Results for the First Half of 2022

Company Announcement No. 34 / 2022 Interim report for H1 2022 Zealand Pharma Announces Financial Results for the First Half of 2022 Copenhagen, DK...

ZEAL : 17.59 (+1.21%)
Updated notice to holders of ADSs regarding termination of Deposit Agreement

NOTICE TO HOLDERS OF AMERICAN DEPOSITARY SHARES (“ADSs”)EVIDENCED BYAMERICAN DEPOSITARY RECEIPTS (“ADRs”)REPRESENTING DEPOSITED ORDINARY SHARES...

ZEAL : 17.59 (+1.21%)
Zealand Pharma Announces Voluntary Delisting of American Depositary Shares from the U.S.-Based Nasdaq Global Select Market

Company announcement – No. 32 / 2022 Zealand Pharma Announces Voluntary Delisting of American Depositary Shares from the U.S.-Based Nasdaq Global Select...

ZEAL : 17.59 (+1.21%)
Zealand Pharma Hosts Conference Call on August 11 at 4 pm CET (10am ET) to Present Second Quarter Results for 2022

Company announcement – No. 31 / 2022 Zealand Pharma Hosts Conference Call on August 11 at 4 pm CET (10am ET) to Present Second Quarter Results for...

ZEAL : 17.59 (+1.21%)
Zealand Pharma AS (ZEAL) Stock Jumps 9.1%: Will It Continue to Soar?

Zealand Pharma AS (ZEAL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down...

ZEAL : 17.59 (+1.21%)
ARCT : 19.59 (-6.94%)
Total number of shares and voting rights in Zealand Pharma at June 30, 2022

Company announcement – No. 30 / 2022 Total number of shares and voting rights in Zealand Pharma at June 30, 2022 Copenhagen, DK and Boston, MA, June 30,...

ZEAL : 17.59 (+1.21%)
Iktos and Zealand Pharma to Develop Artificial Intelligence Technology for Peptide Drug Design

Iktos, a company specialized in Artificial Intelligence for new drug design, today announced a research collaboration with Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company...

ZEAL : 17.59 (+1.21%)
Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities

Company announcement – No. 29 / 2022 Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities Copenhagen, DK and...

ZEAL : 17.59 (+1.21%)
Zealand Pharma major shareholder announcement: Credit Suisse Group AG, 2022

Company announcement – No. 28 / 2022 Zealand Pharma major shareholder announcement: Credit Suisse Group AG, 2022 Copenhagen, DK and Boston, MA, 10 June...

ZEAL : 17.59 (+1.21%)

Barchart Exclusives

Here’s a Big Reason to Like Simon Property Group Other Than Real Estate
Retail REIT Simon Property Group reported stronger-than-expected Q4 2022 results on Monday. But, looking ahead, it sees lower cash flow in 2023. Despite the cloudy profit picture, there’s a big reason to like SPG stock beyond real estate. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar